CARPOOL Study Compares Radial and Femoral Access for PAD Treatment

May 6, 2026—In the CARPOOL study, radial-to-peripheral (R2P) access achieved procedural success rates comparable to traditional common femoral artery (CFA) access for lower extremity peripheral artery disease (PAD) revascularization.

Merit Launches Prelude Wave Hydrophilic Sheath Introducer With SnapFix Technology

August 12, 2025—Merit Medical Systems, Inc. recently announced the United States commercial release of the Prelude Wave hydrophilic sheath introducer with SnapFix securement technology.

Biotronik Partners With Egg Medical to Market EggNest Radiation Protection Systems

February 19, 2025—Biotronik announced it is partnering with Egg Medical, Inc. to cosell Egg Medical’s EggNest radiation protection systems for health care workers in the United States.

Terumo’s R2P NaviCross Peripheral Support Catheter Launched in United States

December 3, 2024—Terumo Interventional Systems, a division of Terumo Corporation, announced the expansion of the company’s radial-to-peripheral (R2P) portfolio with the launch of its R2P NaviCross peripheral support catheter in the United States.

Terumo and NAMSA Form Strategic Outsourcing Partnership

October 15, 2024—Terumo and NAMSA announced a strategic outsourcing partnership.

Transit Scientific Introduces XO Cath Embolic-Delivery Microcatheter

July 9, 2024—Transit Scientific announced the first commercial use of the XO Cath embolic-delivery microcatheter for interventional radiology and interventional oncology applications.

AngioDynamics’ Auryon XL Radial Access Catheter Receives FDA 510(k) Clearance

January 23, 2024—AngioDynamics, Inc. announced that the FDA has cleared the company’s Auryon XL catheter, a 225-cm radial access catheter, for use with the Auryon atherectomy system in the treatment of peripheral artery disease (PAD).

Cordis SMART Radianz Vascular Stent System Evaluated in European RADIANCY Study

November 16, 2023—Cordis announced the completion of patient enrollment in the RADIANCY premarket clinical study.

Study Assesses Safety and Efficacy of Radial Access for Peripheral Artery Interventions

October 16, 2023—The Society for Cardiovascular Angiography & Interventions (SCAI) announced the publication of findings from a study evaluating the safety and feasibility of using radial access (RA) for complex endovascular lower extremity interventions to treat peripheral artery disease.

Merit Introduces 165-cm Length of Maestro Microcatheter Line for Radial Embolization

October 10, 2023—Merit Medical Systems, Inc. announced the expansion of its Maestro microcatheter product line to include a new longer length for radial embolization procedures.

MicroVention Sofia EX 5-F, 115-cm Intracranial Support Catheter Cleared for Transradial Access

September 21, 2023—MicroVention, Inc., a neurovascular company and wholly owned subsidiary of Terumo Corporation, announced that the Sofia EX 5-F, 115-cm intracranial support catheter has received FDA 510(k) clearance for transradial access in addition to transfemoral access.

Surmodics’ Sublime Radial Access Microcatheter Used in First Procedures

April 19, 2023—Surmodics, Inc. announced the first procedures with the company’s Sublime radial access microcatheter, which is in limited market evaluation.

Terumo Registry Evaluates Radial Access in Visceral Interventions in Embolization Procedures

March 13, 2023—Terumo Medical Corporation announced the final results of its study demonstrating the safety and efficacy of “Radial Access in Visceral Interventions” (R.A.V.I.) in standard embolization procedures for uterine fibroids, benign prostatic hyperplasia, as well as liver and other hypervascular tumors.

Merit Medical’s PreludeSync EZ Radial Compression Device Launched in United States

November 21, 2022—Merit Medical Systems, Inc. announced the commercial release of the PreludeSync EZ radial compression device in the United States.

Radial Approach Evaluated With Terumo’s R2P Misago Stent to Treat Complex Lower Extremity PAD

September 27, 2022—Terumo Medical Corporation recently announced data demonstrating the safety and efficacy of radial to peripheral interventions with the company’s R2P Misago self-expanding peripheral stent in lower extremity endovascular interventions via a radial approach.

Cordis’ SMART Radianz Transradial Vascular Stent System Studied in Europe

July 14, 2022—Cordis announced the start of the RADIANCY premarket clinical study in Europe.

Cordis’ Radianz Radial Peripheral System Used in First-in-Human Procedure

June 16, 2022—Cordis announced that the first-in-human use of the Radianz radial peripheral system was performed by Jihad Mustapha, MD, at Advanced Cardiac & Vascular Centers (ACV) in Grand Rapids, Michigan.

Cordis’ S.M.A.R.T. Radianz Transradial Vascular Stent System Approved by FDA

March 10, 2022—Cordis announced that the FDA has approved the SMART Radianz vascular stent system, a self-expanding stent for radial peripheral procedures.

BD’s Halo One Thin-Walled Guiding Sheath Offered in Additional Sizes

December 20, 2021—BD (Becton, Dickinson and Company) announced the launch of additional sizes of the Halo One thin-walled guiding sheath for use in peripheral arterial and venous procedures requiring percutaneous introduction of intravascular devices.

Surmodics’ Sublime Radial Access .018 RX PTA Dilatation Catheter Used in First Clinical Procedures After FDA Clearance

September 29, 2021—Surmodics, Inc. announced the successful first clinical uses of the Sublime radial access .018 RX percutaneous transluminal angioplasty (PTA) dilatation catheter.